POC (ポイントオブケア) コレステロール検査の世界市場
POC (Point of Care) Cholesterol Testing Market
|出版日||ページ情報||英文 37 Pages
|POC (ポイントオブケア) コレステロール検査の世界市場 POC (Point of Care) Cholesterol Testing Market|
|出版日: 2016年01月26日||ページ情報: 英文 37 Pages||
ポイントオブケア (POC) 検査は患者がいる場所で、またはその近くで実施される診断検査で、試験所スタッフのほか、医師や看護師、薬剤師、あるいは患者自身が行なう場合もあります。POC検査のメリットのひとつは、検査結果が即時にわかることで、患者のための治療の判断を迅速に行えることです。
当レポートでは、世界のPOC (ポイントオブケア) コレステロール検査市場について調査し、POC検査の概要、市場の動向と2020年までの成長予測、および主要参入企業のプロファイルをまとめています。
Point of care (POC) tests - diagnostic tests that are performed at or near the site where the patient is located - may be performed by laboratory personnel, but often are performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). The menu for POC testing includes cholesterol testing. Point of Care (POC) Cholesterol Testing Market analyzes the market for this segment of POC testing.
The report examines the following components of the POC cholesterol market:
One of the key benefits and market drivers for the point of care (POC) testing market is the ability to have rapid results that can be used immediately for patient treatment decisions.
The professional sector is made up of tests used in hospitals, physician offices and clinics. In the core lab, cholesterol testing has gained importance, driven by growing awareness about the risks of heart attack and increasing realization among individuals to control their cholesterol levels. Overall growth in testing volume is driven by factors such as aging population and growing number of people at risk of cardiovascular disease including those with hypertension, diabetes mellitus, and abdominal obesity.
Industry professionals had anticipated that patient self-testing would grow because of rising consumer expectations, technological innovations, and the surge of consumer activism in healthcare. Further pharmacies, retail outlets and the physician office are establishing their position for patient wellness screening. Tests for UTIs, H. pylori, cholesterol PSA, TSH, drugs of abuse and others are readily available in all developed countries. However, these have not caught the imagination of consumers. One of the major issues is that of test interpretation, not so much of the actual result but what the result implies.
Cholesterol testing as an aid to diagnosis of cardiovascular disease and diabetes is discussed, as well as how cholesterol testing may be used in conjunction with the measurement of cardiac biomarkers.
The top and/or innovative competitors discussed within Corporate Profiles are: